Sign in
Taking peopleNo phase

Breastfeeding and the chance of gestational diabetes in the next pregnancy

Looks at whether breastfeeding relates to gestational diabetes in women who become pregnant again.

Key facts

Who runs it
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Where
Türkiye2 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Protective Effect of Lactation Against Gestational Diabetes Mellitus in Subsequent Pregnancies: A Prospective Observational Cohort Study
Status
Recruiting
People taking part
140 people, planned
Started
15 Jan 2026
Expected to end
31 Dec 2027
Type of study
Observational
Record updated
3 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women who became pregnant while still breastfeeding. It studies whether breastfeeding lowers the risk of diabetes during pregnancy.

Age
18 to 50 years
Sex
Women only
Disease stage
Pregnant with one baby (not twins or more). The pregnancy began during the breastfeeding period.
Biomarker or test result
Results must be available for fasting blood sugar, HbA1c, sugar in the urine and a 75-g oral glucose tolerance test (OGTT). Routine ultrasound measurements of the baby and the fluid around it must also be available.

Main reasons for not taking part

  • Pregnant with twins or more babies
  • Known long-term disease affecting the whole body
  • Diabetes that started before the pregnancy
  • Missing clinical, lab or ultrasound data
  • Follow-up not at Prof. Dr. Cemil Taşcıoğlu City Hospital or Esenyurt Necmi Kadıoğlu State Hospital

This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant individuals aged 18 to 50 years.

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Pregnant individuals aged 18 to 50 years
  • Singleton pregnancy
  • Conception during the lactation period
  • Follow-up at Prof. Dr. Cemil Taşcıoğlu City Hospital or Esenyurt Necmi Kadıoğlu State Hospital
  • Availability of glycemic parameters including fasting plasma glucose, HbA1c, glycosuria, and 75-g oral glucose tolerance test (OGTT) results
  • Availability of routine ultrasonographic measurements including fetal abdominal circumference percentile (AC), estimated fetal weight percentile (EFW), and amniotic fluid index (AFI)

Who cannot take part

  • Known chronic systemic disease or pre-existing diabetes mellitus
  • Missing clinical, laboratory, or ultrasonographic data
  • Age below 18 years
  • Age above 50 years
  • Multiple pregnancy

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

This trial is currently available in Türkiye.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Gestational diabetes mellitus (GDM) is a common metabolic disorder of pregnancy associated with increased maternal and fetal morbidity. Lactation has been suggested to improve maternal glucose metabolism, enhance insulin sensitivity, and reduce the risk of future glucose intolerance. However, evidence regarding the protective effect of lactation on the development of GDM in subsequent pregnancies remains limited.

Read full original descriptionShow less

This prospective observational cohort study aims to evaluate the association between lactation and the risk of gestational diabetes mellitus and related pregnancy complications in women who conceive during the lactation period. Routine glycemic markers including fasting plasma glucose, HbA1c, glycosuria, and 75-g oral glucose tolerance test (OGTT) results will be recorded. Ultrasonographic findings including fetal abdominal circumference percentile, estimated fetal weight percentile, and amniotic fluid index will also be assessed. The study will investigate whether lactation is associated with a reduced risk of GDM, fetal macrosomia, and polyhydramnios in subsequent pregnancies.

The group in the trial

  • Pregnant Women During Lactation Period

    Singleton pregnant women aged 18-50 years who conceived during the lactation period and were followed at participating obstetrics and gynecology clinics.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Protective Effect of Lactation Against Gestational Diabetes Mellitus in Subsequent Pregnancy: A Prospective Observational Cohort Study
Plain-language title
Breastfeeding and the chance of gestational diabetes in the next pregnancyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07624968, who can take part
Record updated
3 June 2026